Global Vitamins, Minerals, and Supplements CDMO Market 2025 – 2034
<p><strong>Reports Description</strong> <p>As per the <strong>Vitamins Minerals and Supplements CDMO Market </strong>analysis conducted by the CMI team, the vitamins, minerals, and supplements CDMO market is expected to record a <strong>CAGR of 9.95%</strong> from 2025 to 2034. In 2025, the market size was <strong>USD 46.55 Billion</strong>. By 2034, the valuation is anticipated to reach <strong>USD 105.90 Billion</strong>.</p></p> <h3>Overview</h3> <p>Vitamins, minerals, and supplements The CDMO market is gaining traction owing to rising demand for natural and organic products that extend support to wellness and health. Technological advancements like robotic process automation (RPA), AI, augmented reality, virtual reality, and 3D printing trends do increase efficiency during production and formulation. The 3D printing techniques have resulted in newfangled ventures for rendering better delivery of drugs.</p> <p>Additionally, CDMOs are expanding in underdeveloped geographies. For instance, Akums Drugs & Pharmaceuticals, in March 2023, did make an entry into the nutraceutical gummies market. The personalized products have been designed for delivering a convenient dosage to adults, geriatrics, and pediatrics.</p> <h3>Key Trends & Drivers</h3> <ul> <li><strong>Rising Demand for Personalized Nutrition</strong></li> </ul> <p>Personalized nutrition calls for a broader range of adaptable manufacturing processes. The consumers are also asking for innovative formats such as softgels and gummies, which need manufacturing and formulation techniques. Smaller brands and start-ups prefer personalized nutrition due to a lack of manufacturing facilities in-house. They do rely on the CDMOs for handling production and development of their customized products. Supplements are being asked for to address health concerns such as immune support, cognitive function, and graceful aging. The CDMOs are helping brands in manufacturing and developing products that hit personalized wellness goals.</p> <h3>What's trending in the Vitamins, Minerals, and Supplements CDMO Market?</h3> <p>There is an increasing preference for non-pill formats like liquids, gummies, and single-serve powders, which have been looked upon as more enjoyable and convenient. The brands are also expanding the product lines to include herbal ingredients such as Ashwagandha in order to appeal to the consumers looking for natural options. Though North America dominates the market, the Asia Pacific is expected to witness the fastest rate of growth, with China at the forefront. The CDMOs are exploring usage of AI-powered solutions for improving efficiency in sourcing, quoting, and quality assurance.</p> <h3>Key Threats</h3> <p>The vitamins, minerals, and supplements CDMO market is likely to be threatened by changing and diverse regulations across various regions, which need sizable expertise for navigating and ensuring compliance. Also, ascertaining consistent product safety, quality, and precise labeling is a major threat owing to complexity on the part of formulations, potential variability with respect to natural ingredients, and the need for accuracy in production.</p> <p>Also, the potential danger of higher doses of some minerals and vitamins, if consumed daily, is likely to limit expansion of the market and pose a risk to safety, which CDMOs need to manage. Also, conflicts, trade tensions, and shifting policies are likely to disturb cross-border operations, investment decisions, and sourcing materials.</p> <h3>Opportunities</h3> <p>The consumers are extensively seeking customized health solutions, whereby they are generating demand for the CDMOs to manufacture and develop personalized supplement formulations. As various supplements are devoid of in-house infrastructure regarding production and development, they result in outsourcing the tasks to CDMOs for focusing on core competencies and minimizing time-to-market.</p> <p>Also, higher emphasis on wellness and health, especially amongst Gen Z and millennials, is driving demand for the vitamins, minerals, and supplements CDMOs. Also, companies are increasingly focusing on expertise in softgel production.</p> <h3>Category Wise Insights</h3> <p><strong>By Type </strong></p> <ul> <li><strong>Vitamins</strong></li> </ul> <p>The consumers, particularly the youth, are aspiring to have personalized supplements addressing specified needs, thereby allowing the CDMOs to develop novel formulations and offer various flexible options of manufacturing. The world is witnessing a shift to more convenient and diverse formats such as softgels, gummies, and powders. The CDMOs are important for brands that intend to develop such delivery systems. Also, the brands are increasingly depending on CDMOs for providing specialized expertise in product development, formulation, and manufacturing.</p> <ul> <li><strong>Minerals</strong></li> </ul> <p>The rising demand for more effective mineral-based products does drive the CDMOs to come up with new formulations. This constitutes the creation of supplements with improved bioavailability or the ones that are simpler to use – like gummies, liquids, and powders. The CDMOs are capable of using advanced synthetic chemistry as well as processing techniques for creating consistent, high-purity mineral products. They make way for infrastructure that brands may not be able to create in-house, thereby allowing them to upscale the production of complex supplements in an efficient manner.</p> <ul> <li><strong>Dietary Supplements</strong></li> </ul> <p>Growing awareness regarding wellness, preventive healthcare, and advantages of supplements for specific needs such as immune support and general health does create higher consumer demand that should be met by the manufacturers. Consumers are increasingly demanding tailored solutions for fulfilling their individual health goals. The consumers are preferring more convenient and palatable forms of the supplements, like chews and gummies, over conventional capsules or pills.</p> <p><strong>By Dosage Form </strong></p> <ul> <li><strong>Tablets & Capsules</strong></li> </ul> <p>Tablets & capsules do account for the biggest share of the vitamins, minerals, and supplements CDMO market due to the higher convenience quotient on their part. These forms do accommodate a broad array of minerals, vitamins, and the other supplements with the least usage of excipients along with the provision of a stable product. Capsules could be produced in several designs and colors, thereby allowing for branding and differentiation of product, which is a benefit for the CDMOs for offering their clients.</p> <ul> <li><strong>Powder</strong></li> </ul> <p>Powdered supplements do allow for certain ingredients’ higher dosages and address the rising demand for personalized products such as functional food powders, while also enabling dose flexibility and simpler consumption for the end-users. CDMOs are capable of producing custom powder formulations for addressing consumer needs like keto, allergen-free, or keto products. The ongoing trend of customized nutrition does create opportunities for the CDMOs to deliver the powdered formulations tailored to customers.</p> <ul> <li><strong>Softgel</strong></li> </ul> <p>Softgels are simpler to swallow and usually perceived as being more palatable as compared to tablets, thereby raising consumer adherence. Softgel form holds the capability of providing superlative bioavailability for some nutrients, especially the fat-soluble oils and vitamins, thereby resulting in higher demand for effective encapsulation on their part. Also, softgel’s airtight seal does render protection to sensitive ingredients from oxygen and moisture, which extends its shelf life.</p> <p><strong>By Company Size </strong></p> <ul> <li><strong>Small Companies</strong></li> </ul> <p>Small companies are the basic drivers of demand pertaining to non-pill, innovative formats such as liquids, gummies, effervescent powders, and customized nutrition solutions. Their emphasis on the novel trends does push the CDMOs toward investment in R&D capabilities and new technologies for offering such specialized services. They, by offloading capital-intensive and complex regulatory and manufacturing burdens to CDMOs, can concentrate on branding, product idea generation, sales, and marketing.</p> <ul> <li><strong>Mid-sized Companies</strong></li> </ul> <p>Mid-sized companies are capable of adapting processes for meeting specified ingredient sourcing, packaging needs, and formulation, which is important for the rising demand for customized nutrition. Such CDMOs emphasize niche therapies or exclusive product categories, thereby rendering them more responsive and agile to novel developments than more diversified players. The CDMOs do provide expertise regarding navigation of complex regulatory frameworks, which is necessary for ascertaining product compliance and safety.</p> <ul> <li><strong>Large Companies</strong></li> </ul> <p>Large companies are investing handsomely in the expansion of manufacturing capacity. For instance, Lonza has invested 93 Mn USD for increasing production of softgel. Collaborations such as CVC Credit being the torchbearer for a debt facility to acquire a U.S.-based pharma lab facilitate strategic positioning of the market. The large companies enable integrating scientific research into the development of products, thereby creating clinically validated, evidence-based, and sophisticated formulations with ingredients’ optimized blends.</p> <p><strong>By Service Type </strong></p> <ul> <li><strong>Product Formulation and Development</strong></li> </ul> <p>CDMOs are into the creation of popular formats such as softgels and gummies for meeting consumers’ demand for better tasting and simpler to swallow products. The rising demand for personalized supplements tailored for specific lifestyles, health needs, and genetics is resulting in data-driven formulations that could be developed by CDMOs.</p> <ul> <li><strong>Manufacturing and Packaging</strong></li> </ul> <p>CDMOs do provide specialized knowledge as well as infrastructure for obtaining efficient production that includes complex formulas and several forms of dosage, which brands may not be able to provide internally. Innovative packaging solutions include e-Commerce-friendly formats, smart features such as digital and track-and-trace interfaces, and sustainable materials that do improve consumer engagement.</p> <ul> <li><strong>Research & Development</strong></li> </ul> <p>CDMOs are leveraging R&D activities for developing clinically validated, evidence-based supplements and providing specialized expertise in order to create personalized nutrition products, thereby adding to the value proposition for the vitamins, minerals, and supplements. R&D advancements have resulted in a better understanding of synergistic effects of diverse nutrients. The CDMOs make use of this knowledge for formulating complex blends.</p> <ul> <li><strong>Regulatory Compliance</strong></li> </ul> <p>Regulatory compliance is one of the major concerns for nutraceutical brands owing to stern oversight like the regulations set by the U.S. FDA. The CDMOs specializing in navigation of such rules do help brands in ensuring that their products meet quality, safety, and labelling standards, which, in turn, does build consumers’ confidence and reduces risk of recalls and penalties.</p> <h3>Historical Context</h3> <p>Vitamins, minerals, and supplements CDMOs are providing various comprehensive services for the production, development, and packaging of the dietary supplements inclusive of minerals, herbal products, and vitamins. He CDMOs are important from the perspective of helping the brands in bringing innovative formulations to the market while ascertaining compliance and maintaining the higher quality of manufacturing processes.</p> <p>Specialty brands and multilevel marketing, which tend to outsource formulation, manufacturing, sourcing, and packaging for the majority of their products, do value the CDMOs offering shorter lead times and newfangled R&D capabilities.</p> <h3>How is AI shaping the Vitamins, Minerals, and Supplements CDMO Market?</h3> <p>AI algorithms could be used by CDMOs for analyzing vast datasets comprising microbiome data, genetic information, dietary habits, and wearable device metrics for recommending and producing custom supplement protocols catering to the health needs of an individual. This is allowed for personalized batch production, which was cost-prohibitive before.</p> <p>Machine learning algorithms are capable of scanning hordes of clinical studies for identifying synergistic ingredient combinations, predicting effective doses, and filtering out the potential side effects. AI models do simulate interaction as well as performance parameters (such as absorption rates and stability), thereby allowing for designing optimized delivery formats (such as softgels or gummies) without excessive physical testing.</p> <h3>How are the U.S. Tariffs affecting Vitamins, Minerals, and Supplements CDMO Market?</h3> <p>The vitamins, minerals, and supplements CDMO market heavily relies on ingredients sourced globally, with India and China being the key suppliers. Tariffs on botanicals, APIs, and the other components (specific vitamins such as ascorbic acid) have resulted in noticeable increases in costs (12 to 25%) for the CDMOs, which, in several cases, get passed on to brands and ultimately the consumers. The CDMOs based in the U.S. are witnessing a rise in Requests for Proposals (RFPs) for production at the domestic level. Various brands outside the U.S. are also adopting the “China + 1” strategy, whereby they can diversify their manufacturing and sourcing to Mexico, Vietnam, India, and the other Southeast Asian economies. This is bound to create growth opportunities for the CDMOs in these alternative regions.</p> <p><strong>Report Scope</strong></p> <table> <tbody> <tr> <td><strong>Feature of the Report</strong></td> <td><strong>Details</strong></td> </tr> <tr> <td>Market Size in 2025</td> <td>USD 46.55 Billion</td> </tr> <tr> <td>Projected Market Size in 2034</td> <td>USD 105.90 Billion</td> </tr> <tr> <td>Market Size in 2024</td> <td>USD 42.34 Billion</td> </tr> <tr> <td>CAGR Growth Rate</td> <td>9.95% CAGR</td> </tr> <tr> <td>Base Year</td> <td>2024</td> </tr> <tr> <td>Forecast Period</td> <td>2025-2034</td> </tr> <tr> <td>Key Segment</td> <td>By Type, Dosage Form, Company Size, Service Type and Region</td> </tr> <tr> <td>Report Coverage</td> <td>Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends</td> </tr> <tr> <td>Regional Scope</td> <td>North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America</td> </tr> <tr> <td>Buying Options</td> <td>Request tailored purchasing options to fulfil your requirements for research.</td> </tr> </tbody> </table> <h3>Regional Perspective</h3> <p>The <a href="https://custommarketinsights.com/press-releases/vitamins-minerals-and-supplements-cdmo-market-size/">vitamins, minerals, and supplements CDMO market</a> is classified into North America, Europe, Asia Pacific, and LAMEA.</p> <ul> <li><strong>North America</strong></li> </ul> <p>North American CDMOs are the torchbearers of innovation, which emphasize research and development activities for creating advanced formulations addressing the altering consumer preferences. The region’s well-established regulatory frameworks like the Dietary Supplement Health and Education Act (DSHEA), do build confidence and trust for consumers as well as brands regarding compliance and brands. The rising geriatric population also drives the market, with increased requirements for the supplements for catering to the age-related concerns.</p> <ul> <li><strong>Asia Pacific</strong></li> </ul> <p>The Asia Pacific is bound to witness the fastest CAGR in the vitamins, minerals, and supplements CDMO market during the forecast period. This could be credited to the fact that CDMOs are being encouraged to provide one-stop, comprehensive solutions for production, formulation, and packaging for addressing the market demand. The digital solutions like app-based dosage management are also enhancing consumer compliance. The China Health Food Registration System is simplifying regulatory pathways, thereby making it simpler for the companies to come up with novel products.</p> <ul> <li><strong>Europe</strong></li> </ul> <p>Europe’s increasing geriatric population is driving the demand for various supplements to address the age-related concerns like joint, bone, and cognitive health, thereby creating a long-term, stable market for specified products that CDMOs are capable of manufacturing. The consumers based in Europe are showing a strong inclination toward clean-label supplements with numerous scientifically backed claims. The CDMOs adopting advanced manufacturing technologies are vital with regard to the development and production of such new formats, which several brands lack in-house.</p> <ul> <li><strong>LAMEA</strong></li> </ul> <p>Consumers all across LAMEA are turning out to be more proactive regarding management of their wellbeing and seeking measures pertaining to preventive healthcare, thereby resulting in an increased demand for dietary supplements. Economies like Brazil are witnessing a noticeable rise in aging populations, which need more supplements for addressing the age-related concerns. The brands aiming to strengthen their base in such markets need localized manufacturing capabilities that could be served by CDMOs through partnerships with local players.</p> <h3>Key Developments</h3> <p>The vitamins, minerals, and supplements CDMO market is witnessing a notable organic and inorganic expansion. Some of the key developments include -</p> <ul> <li>In February 2023, <a href="https://www.lonza.com/">Lonza</a> announced the expansion of the bioconjugation facility in Visp (CH), Switzerland. Prior to that (in October 2020), it had invested USD 93 Million into its “capsule and health ingredient’ division with the objective of significantly increasing the softgel production capacity across 8 facilities worldwide.</li> </ul> <h3>Leading Players</h3> <p>The vitamins, minerals, and supplements CDMO market is highly niche. Some of the key players in the market include:</p> <ul> <li>Catalent Inc.</li> <li>Lonza</li> <li>Nutrascience Labs</li> <li>Robinson Pharma Inc.</li> <li>Health Wright Products Inc.</li> <li>INPHARMA S.p.A.</li> <li>Aenova Group</li> <li>NutraPak USA</li> <li>SFI Health</li> <li>Others</li> </ul> <p>These firms apply numerous strategies to enter the market, including innovations and mergers and acquisitions, as well as collaboration. The vitamins, minerals, and supplements CDMO market is shaped by the presence of diversified players that compete based on product innovation, vertical integration, and cost efficiency.</p> <p>The <strong>Vitamins, Minerals, and Supplements CDMO Market</strong> is segmented as follows:</p> <p><strong>By Type </strong></p> <ul> <li>Vitamins</li> <li>Minerals</li> <li>Dietary Supplements</li> </ul> <p><strong>By Dosage Form </strong></p> <ul> <li>Tablets & Capsules</li> <li>Powder</li> <li>Softgel</li> </ul> <p><strong>By Company Size </strong></p> <ul> <li>Small Companies</li> <li>Mid-sized Companies</li> <li>Large Companies</li> </ul> <p><strong>By Service Type </strong></p> <ul> <li>Product Formulation and Development</li> <li>Manufacturing and Packaging</li> <li>Research & Development</li> <li>Regulatory Compliance</li> </ul> <p><strong>Regional Coverage:</strong></p> <p><strong>North America</strong></p> <ul> <li>U.S.</li> <li>Canada</li> <li>Mexico</li> <li>Rest of North America</li> </ul> <p><strong>Europe</strong></p> <ul> <li>Germany</li> <li>France</li> <li>U.K.</li> <li>Russia</li> <li>Italy</li> <li>Spain</li> <li>Netherlands</li> <li>Rest of Europe</li> </ul> <p><strong>Asia Pacific</strong></p> <ul> <li>China</li> <li>Japan</li> <li>India</li> <li>New Zealand</li> <li>Australia</li> <li>South Korea</li> <li>Taiwan</li> <li>Rest of Asia Pacific</li> </ul> <p><strong>The Middle East & Africa </strong></p> <ul> <li>Saudi Arabia</li> <li>UAE</li> <li>Egypt</li> <li>Kuwait</li> <li>South Africa</li> <li>Rest of the Middle East & Africa</li> </ul> <p><strong>Latin America</strong></p> <ul> <li>Brazil</li> <li>Argentina</li> <li>Rest of Latin America</li> </ul>
Report Code
HF6487
Published
November 12, 2025
Pages
320+
Format
PDF, Excel
Revenue, 2024
—
Forecast, 2034
—
CAGR, 2025-2034
9.95%
Report Coverage
Global
Executive Summary
This report provides comprehensive analysis of the healthcaresector in the healthcare industry. Our research covers market trends, key players, growth opportunities, and strategic recommendations.
Key Findings
- Market size and growth projections
- Competitive landscape analysis
- Regulatory environment overview
- Technology trends and innovations
Market Overview
The healthcare market continues to evolve with new technologies, changing regulations, and shifting patient demographics. This section provides detailed insights into current market conditions.
